Interpreta Spotlights Regulatory Landscape for Clinical Sequencing

Ben Yu

In an invited meeting review, Interpreta Vice President of Clinical Informatics and Genomics, Dr. Benjamin Yu, reports on the industry landscape and positions of governmental, academic, professional, patient advocacy and manufacturing groups on clinical regulation of next generation sequencing (NGS). The meeting which took place in February was sponsored by the FDA was public discussion… Read more »

Spread the love
READ MORE »